Skip Navigation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lebowitz, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lebowitz, M. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Vol 19, S43-S47, Copyright © 1990 by International Epidemiological Association


ARTICLES

Methodological issues in the epidemiological investigations of lung cancer related to low-level risks

MD Lebowitz
Division of Respiratory Sciences, University of Arizona College of Medicine, Tucson 85724.

There are several major issues that create great difficulties in the study of low-level risks for lung cancer. Further attention needs to be addressed to the difficulties in design, ascertainment, classification, confounding and analysis found in the environmental epidemiological aspects of the investigation. Host predisposition is an important factor that requires further characterization in the process of conducting these environmental epidemiological investigations. Within the exposure assessment aspects of these investigations, major difficulties arise from the need to obtain total exposure estimates, dose estimates and in evaluating the interactions of the several pollutants of concern in exposure settings of interest. Low-level risks for lung cancer imply difficulties in the assessment of exposure-dose pattern. Further, bio-markers are needed to focus more on dose. Further, low-level risk ratios produce difficulties in distinguishing the effects of confounders. In order to facilitate further studies of lung cancer related to low-level risks, we will have to create new, more specific, and more efficient study designs. These studies will require much better exposure assessment and case ascertainment than typical of previous studies, and more complete measurement of confounders.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.